Anat Mirelman

Also affiliated with Tel Aviv Sourasky Medical Center

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Long-term unsupervised mobility assessment in movement disorders”.

Long-term unsupervised mobility assessment in movement disorders

The Lancet Neurology(2020)10.1016/s1474-4422(19)30397-7

N/A

0DataRank · unranked

329 citations

Jeffrey M. Hausdorff, Arash Atrsaei, Yuhan Zhou, Anat Mirelman, Kamiar Aminian +11 more

Automatic Quantification of Tandem Walking Using a Wearable Device: New Insights Into Dynamic Balance and Mobility in Older Adults

The Journals of Gerontology Series A(2020)10.1093/gerona/glaa235

N/A

0DataRank · unranked

11 citations

Eran Gazit, Nir Giladi, Robert J. Dawe, Anat Mirelman, Aron S. Buchman +2 more

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients

Clinical Parkinsonism & Related Disorders(2020)10.1016/j.prdoa.2020.100042

N/A

0DataRank · unranked

9 citations

Anat Mirelman, Rachel Saunders‐Pullman, Helen Mejia‐Santana, Elise Caccappolo, Deborah Raymond +5 more

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease

medRxiv(2020)10.1101/2020.12.14.20224378

N/A

0DataRank · unranked

10 citations

Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay +55 more

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

Annals of Neurology(2021)10.1002/ana.26094

N/A

0DataRank · unranked

50 citations

Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay +56 more

PARK16 locus: Differential effects of the non-coding rs823114 on Parkinson’s disease risk, RNA expression, and DNA methylation

Journal of genetics and genomics/Journal of Genetics and Genomics(2021)10.1016/j.jgg.2020.10.010

N/A

0DataRank · unranked

6 citations

Mali Gana‐Weisz, Fergal Casey, Hila Meltzer-Fridrich, Or Yaacov, Yedael Y. Waldman +13 more

Transcranial Direct Current Stimulation May Reduce Prefrontal Recruitment During Dual Task Walking in Functionally Limited Older Adults – A Pilot Study

Frontiers in Aging Neuroscience(2022)10.3389/fnagi.2022.843122

N/A

0DataRank · unranked

8 citations

Hagar Bernad‐Elazari, Anat Mirelman, Natalia Gouskova, On‐Yee Lo, Jeffrey M. Hausdorff +2 more

Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

Movement Disorders(2023)10.1002/mds.29288

N/A

0DataRank · unranked

50 citations

Susen Schaake, Katja Lohmann, Shalini Padmanabhan, Alexis Brice, Suzanne Lesage +95 more

Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple Sclerosis

Archives of Physical Medicine and Rehabilitation(2024)10.1016/j.apmr.2024.09.010

N/A

0DataRank · unranked

9 citations

Irina Galperin, Danya Pradeep Kumar, Anat Mirelman, Shahar Yehezkyahu, Keren Regev +11 more

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies

Movement Disorders(2024)10.1002/mds.30003

N/A

0DataRank · unranked

1 citations

Gitit Kavé, Anat Mirelman, Keren Regev, Yoav Piura, Orly Goldstein +8 more

Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review

Movement Disorders(2025)10.1002/mds.70097

N/A

0DataRank · unranked

5 citations

Chaewon Shin, Siegfried Hirczy, Harini Sarva, Serene S. Paul, Walter Maetzler +22 more